Logo Image
News
All NewsFDA UpdatesPress Releases
Watch
Expert ConversationsNews & AnalysisShows & PodcastsSponsored Webcast
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsMicrositesPartnersPulsePointSponsoredWhiteboards

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • Allergy
    • Asthma
  • Biosimilars
  • Cardiovascular Health
    • Heart Failure
    • Cholesterol
  • Chronic Kidney Disease
  • Classical Hematology
    • Immunoglobulins
    • Neutropenia
  • Dermatology
    • Psoriasis
    • Atopic Dermatitis
  • Endocrinology
    • Continuous Glucose Monitoring
    • Diabetes
    • Osteoporosis
  • Eye Care
    • Macular Degeneration
    • Dry Eye Disease
  • Future of Pharmacy
  • Gastrointestinal Health
    • Digestive Health
  • Hematology
    • Multiple Myeloma
    • Lymphoma
    • Myelofibrosis
    • Chronic Lymphocytic Leukemia
  • Hepatitis/MASH
  • Infectious Disease
    • Respiratory Syncytial Virus
    • Pneumococcal
    • C. difficile
    • COVID-19
    • Flu
    • HIV
    • PrEP
    • COVID Treatment
  • Neurology
    • Multiple Sclerosis
    • Alzheimer Disease
    • Epilepsy
    • Migraine
    • Sleep
    • Shingles
    • Alzheimer Disease
    • Movement Disorders
    • Parkinson Disease
  • Oncology
    • Cholangiocarcinoma
    • Endometrial Cancer
    • Immuno-oncology
    • Genitourinary Cancer
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Ovarian Cancer
    • Breast Cancer
    • Cervical Cancer
    • Gastrointestinal Cancer
    • Colorectal Cancer
    • HER2 Breast Cancer
  • Pain Management
  • Pediatrics
  • Psychiatry
    • Psychedelics
    • Schizophrenia
    • ADHD
    • Brain Health
    • Mental Health
    • Bipolar Disorder
    • Anxiety
    • Depression
  • Pulmonology
    • COPD
    • Cough and Cold
  • Rheumatology
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
  • Vaccines
    • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
    • Reproductive Health
Spotlight -
Community/Retail|
Health Systems|
Oncology|
Pharmacy Technician|
Student
Advertisement

Bruce A. Berger, PhD

Advertisement

Articles by Bruce A. Berger, PhD

Making Sense of Motivational Interviewing, Part 2: Clinical, Economic, and Other Evidence

ByBruce A. Berger, PhD,William A. Villaume, PhD
May 5th 2016

Numerous studies have supported the use of motivational interviewing in health care to reduce cholesterol level, blood pressure, blood alcohol level, and weight.

Making Sense of Motivational Interviewing: Part 1

ByBruce A. Berger, PhD,William A. Villaume, PhD
April 13th 2016

Motivational interviewing was widely adopted in addiction counseling and proved to be very effective in helping patients to change their behavior.

Advertisement

Latest Updated Articles

  • Making Sense of Motivational Interviewing: Part 1
    Making Sense of Motivational Interviewing: Part 1

    April 13th 2016

  • Making Sense of Motivational Interviewing, Part 2: Clinical, Economic, and Other Evidence
    Making Sense of Motivational Interviewing, Part 2: Clinical, Economic, and Other Evidence

    May 5th 2016



Advertisement
Advertisement

Trending on Pharmacy Times

1

Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring

2

FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia

3

Pneumonic Plague: What Pharmacists Need to Know About Treatment

4

FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults

5

Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us